Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease
NCT07483398Phase 4Active, not recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of crisugabalin besilate in nociplastic pain, sponsored by Guangdong Provincial People's Hospital. Started Mar 2026; status: active, not recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
nociplastic pain
Beyond the preview
Go deeper on NCT07483398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07483398.